Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Groupon
GRPN
$894M
| $8.25M | ﹤0.01% |
361,529
+26,565
| +8% | +$786K |
|
2127
Ennis
EBF
$559M
| $8.24M | ﹤0.01% |
437,084
+33,613
| +8% | +$660K |
|
2128
GoPro
GPRO
$117M
| $8.2M | ﹤0.01% |
875,543
+8,225
| +0.9% | +$83.2K |
|
2129
BioLife Solutions
BLFS
$1.72B
| $8.17M | ﹤0.01% |
193,073
-10,105
| -5% | -$487K |
|
|
MAGN
2130
Magnera Corp
MAGN
$433M
| $8.12M | ﹤0.01% |
44,284
+2,129
| +5% | +$413K |
|
2131
Zai Lab
ZLAB
$2.92B
| $8.07M | ﹤0.01% |
76,540
+1,625
| +2% | +$233K |
|
|
DNMR
2132
DELISTED
Danimer Scientific, Inc.
DNMR
| $8.07M | ﹤0.01% |
12,341
+1,247
| +11% | +$917K |
|
2133
Ichor Holdings
ICHR
$2.67B
| $8.06M | ﹤0.01% |
196,267
+2,620
| +1% | +$120K |
|
2134
Century Aluminum
CENX
$4.59B
| $8.05M | ﹤0.01% |
598,636
+7,298
| +1% | +$91.7K |
|
|
GDEN
2135
DELISTED
Golden Entertainment
GDEN
| $8.05M | ﹤0.01% |
163,973
+36,850
| +29% | +$1.71M |
|
2136
Northern Oil and Gas
NOG
$2.61B
| $8.01M | ﹤0.01% |
374,448
+49,843
| +15% | +$871K |
|
2137
Pulmonx
LUNG
$92.8M
| $7.98M | ﹤0.01% |
221,866
+117,710
| +113% | +$4.63M |
|
|
IMGN
2138
DELISTED
Immunogen Inc
IMGN
| $7.97M | ﹤0.01% |
1,406,002
-56,233
| -4% | -$325K |
|
2139
Construction Partners
ROAD
$6.73B
| $7.96M | ﹤0.01% |
238,440
+6,571
| +3% | +$216K |
|
2140
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $7.95M | ﹤0.01% |
223,860
+6,625
| +3% | +$223K |
|
2141
Payoneer
PAYO
$2.42B
| $7.94M | ﹤0.01% |
+928,851
| New | +$9.02M |
|
|
CFLT
2142
DELISTED
Confluent
CFLT
| $7.92M | ﹤0.01% |
+132,783
| New | +$6.9M |
|
|
MCFE
2143
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $7.91M | ﹤0.01% |
357,509
+178,924
| +100% | +$4.62M |
|
|
CONN
2144
DELISTED
Conn's Inc.
CONN
| $7.9M | ﹤0.01% |
346,147
+3,550
| +1% | +$84.3K |
|
|
EVOP
2145
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $7.88M | ﹤0.01% |
332,671
+8,203
| +3% | +$218K |
|
|
FFAI
2146
Faraday Future Intelligent Electric
FFAI
$12M
| $7.86M | ﹤0.01% |
+1
| New | +$16.5M |
|
|
MODN
2147
DELISTED
MODEL N, INC.
MODN
| $7.8M | ﹤0.01% |
232,926
+11,072
| +5% | +$374K |
|
2148
Parsons
PSN
$5.08B
| $7.8M | ﹤0.01% |
230,994
+36,031
| +18% | +$1.32M |
|
2149
PC Connection
CNXN
$2.04B
| $7.8M | ﹤0.01% |
177,083
+11,962
| +7% | +$548K |
|
2150
iShares Select Dividend ETF
DVY
$24B
| $7.79M | ﹤0.01% |
67,935
+49,566
| +270% | +$5.79M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.